Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00074737
Status:
COMPLETED
Last Update Posted:
2014-09-18
First Post:
2003-12-19
Brief Title:
Dosing Study of Ara-CEL625Idarubicin in Refractory and Relapsed AML
Sponsor:
Eleos Inc
Organization:
Eleos Inc